Vanguard Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-155,248
Closed -$1.38M 4539
2022
Q3
$1.38M Buy
155,248
+5,267
+4% +$66.3K ﹤0.01% 3890
2022
Q2
$1.9M Hold
149,981
﹤0.01% 3828
2022
Q1
$2.84M Hold
149,981
﹤0.01% 3802
2021
Q4
$5.26M Sell
149,981
-6,067
-4% -$197K ﹤0.01% 3578
2021
Q3
$5.71M Buy
156,048
+20,361
+15% +$801K ﹤0.01% 3573
2021
Q2
$5.33M Sell
135,687
-18,041
-12% -$521K ﹤0.01% 3565
2021
Q1
$4.34M Buy
153,728
+1,734
+1% +$55.3K ﹤0.01% 3601
2020
Q4
$4.87M Buy
151,994
+19,689
+15% +$605K ﹤0.01% 3371
2020
Q3
$4.27M Buy
132,305
+1,647
+1% +$51.3K ﹤0.01% 3232
2020
Q2
$3.6M Buy
130,658
+3,298
+3% +$71.5K ﹤0.01% 3240
2020
Q1
$2.27M Sell
127,360
-768
-0.6% -$18.5K ﹤0.01% 3268
2019
Q4
$3.21M Sell
128,128
-15,298
-11% -$335K ﹤0.01% 3314
2019
Q3
$2.56M Buy
143,426
+15,219
+12% +$317K ﹤0.01% 3369
2019
Q2
$2.82M Sell
128,207
-13,955
-10% -$398K ﹤0.01% 3373
2019
Q1
$4.35M Buy
142,162
+6,401
+5% +$160K ﹤0.01% 3188
2018
Q4
$3.13M Buy
+135,761
New +$4.22M ﹤0.01% 3245

Other funds holding HCM

Vanguard Group's HCM Position: Q4 2022 in Review

Vanguard Group sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 155,248 shares — an estimated $1.38M sold.

Vanguard Group first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $5.71M in Q3 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Vanguard Group reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 155,248 HUTCHMED shares in Q4 2022, an estimated $1.38M.
  • Vanguard Group first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • Vanguard Group's HUTCHMED position peaked at $5.71M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.